Earningsreport

Q3/2024 9/30/2024 EPS -0.890 ZacksConsensus -1.200 ActVsEst 0.310 - Beat

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx